(Q33680336)

28 July 2017

1 reference

title

Administration of fluconazole in children below 1 year of age. (English)

1 reference

28 July 2017

1 reference

Schwarze R

1

1 reference

28 July 2017

Penk A

series ordinal

2

1 reference

28 July 2017

Pittrow L

series ordinal

3

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

42

1 reference

28 July 2017

issue

1-2

1 reference

28 July 2017

page(s)

3-16

1 reference

Systemic candidal infections associated with use of peripheral venous catheters in neonates: a 9-year experience

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Plasma and tissue concentrations of fluconazole and their correlation to breakpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Human and rabbit newborn lung macrophages have reduced anti-Candida activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fungal infection in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Candida strains from neonates in a special care baby unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Candidal sepsis and meningitis in a very-low-birth-weight infant successfully treated with fluconazole and flucytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole in neonatal disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Use of fluconazole in the treatment of Candida albicans hydrocephalus shunt infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Urinary tract candidiasis in neonates and infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Candida lusitaniae osteomyelitis in a premature infant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Prospective study of fluconazole therapy in systemic neonatal fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Early onset systemic Candida infection in extremely preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Antifungal agents in neonatal systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole in the treatment of candidiasis in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Prevention of gram-positive and Candida albicans infections using teicoplanin and fluconazole: a randomized study in neutropenic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Clinical pharmacokinetics of antibacterial drugs in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Amphotericin B blunts erythropoietin response to anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Successful medical treatment of presumed Candida endocarditis in critically ill infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Pharmacokinetics of fluconazole in cerebrospinal fluid and serum in human coccidioidal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Maternofetal disseminated candidiasis and high-grade prematurity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole-resistant Candida albicans in an immunocompetent child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Invasive candidiasis in infants weighing more than 2500 grams at birth admitted to a neonatal intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Candida infection in very low birth-weight infants: outcome and nephrotoxicity of treatment with liposomal amphotericin B (AmBisome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Large-scale multicentre study of fluconazole in the treatment of hospitalised patients with fungal infections. Multicentre European Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1439-0507.1999.00260.X

UCE6, a new antitumor antibiotic with topoisomerase I mediated DNA cleavage activity, from actinomycetes

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.46.1173

Identifiers

DOI

10.1046/J.1439-0507.1999.00260.X

1 reference

28 July 2017

1 reference